COSMOS HEALTH INC (COSM)
US2214133058 - Common Stock
Taking everything into account, COSM scores 2 out of 10 in our fundamental rating. COSM was compared to 107 industry peers in the Health Care Providers & Services industry. COSM may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, COSM is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
COSM had negative earnings in the past year.
In the past year COSM has reported a negative cash flow from operations.
COSM had negative earnings in 4 of the past 5 years.
COSM had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
With a Return On Assets value of -52.41%, COSM is not doing good in the industry: 87.62% of the companies in the same industry are doing better.
COSM's Return On Equity of -96.67% is on the low side compared to the rest of the industry. COSM is outperformed by 79.05% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -52.41% | ||
| ROE | -96.67% | ||
| ROIC | N/A |
ROA(3y)-54.86%
ROA(5y)-35.31%
ROE(3y)-196.24%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
COSM has a Gross Margin of 8.10%. This is amonst the worse of the industry: COSM underperforms 80.95% of its industry peers.
In the last couple of years the Gross Margin of COSM has grown nicely.
The Profit Margin and Operating Margin are not available for COSM so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 8.1% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-17.56%
GM growth 5Y4.63%
2. Health
2.1 Basic Checks
COSM does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, COSM has more shares outstanding
The number of shares outstanding for COSM has been increased compared to 5 years ago.
Compared to 1 year ago, COSM has a worse debt to assets ratio.
2.2 Solvency
COSM has an Altman-Z score of -1.91. This is a bad value and indicates that COSM is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of COSM (-1.91) is worse than 83.81% of its industry peers.
A Debt/Equity ratio of 0.25 indicates that COSM is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.25, COSM is doing good in the industry, outperforming 68.57% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.25 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -1.91 |
ROIC/WACCN/A
WACC6.89%
2.3 Liquidity
COSM has a Current Ratio of 1.44. This is a normal value and indicates that COSM is financially healthy and should not expect problems in meeting its short term obligations.
COSM has a Current ratio (1.44) which is in line with its industry peers.
COSM has a Quick Ratio of 1.24. This is a normal value and indicates that COSM is financially healthy and should not expect problems in meeting its short term obligations.
COSM has a Quick ratio (1.24) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.44 | ||
| Quick Ratio | 1.24 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 71.84% over the past year.
The Revenue has grown by 13.03% in the past year. This is quite good.
Measured over the past years, COSM shows a small growth in Revenue. The Revenue has been growing by 7.56% on average per year.
EPS 1Y (TTM)71.84%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-70.16%
Revenue 1Y (TTM)13.03%
Revenue growth 3Y-1.24%
Revenue growth 5Y7.56%
Sales Q2Q%-3.22%
3.2 Future
COSM is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 41.97% yearly.
Based on estimates for the next years, COSM will show a quite strong growth in Revenue. The Revenue will grow by 15.46% on average per year.
EPS Next Y-21.87%
EPS Next 2Y41.97%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year6.66%
Revenue Next 2Y15.46%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for COSM. In the last year negative earnings were reported.
COSM is valuated quite expensively with a Price/Forward Earnings ratio of 67.25.
COSM's Price/Forward Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.45, COSM is valued quite expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 67.25 |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
COSM's earnings are expected to grow with 41.97% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.97%
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for COSM!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
COSMOS HEALTH INC
NASDAQ:COSM (1/2/2025, 6:18:14 PM)
After market: 0.6801 -0.01 (-0.86%)0.686
+0.02 (+2.54%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners3.33%
Inst Owner Change307.45%
Ins Owners8.99%
Ins Owner Change3.39%
Market Cap16.02M
Analysts82.86
Price Target3.06 (346.06%)
Short Float %1.78%
Short Ratio1.41
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-153.06%
Min EPS beat(2)-301.07%
Max EPS beat(2)-5.04%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-14.09%
Min Revenue beat(2)-15.09%
Max Revenue beat(2)-13.09%
Revenue beat(4)1
Avg Revenue beat(4)-4.24%
Min Revenue beat(4)-15.09%
Max Revenue beat(4)12.94%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-25%
PT rev (3m)-25%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-37.5%
EPS NY rev (1m)-62.5%
EPS NY rev (3m)-65.96%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-17.38%
Revenue NY rev (1m)-2.82%
Revenue NY rev (3m)-2.82%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 67.25 | ||
| P/S | 0.29 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 0.46 | ||
| P/tB | 0.59 | ||
| EV/EBITDA | N/A |
EPS(TTM)-2.23
EYN/A
EPS(NY)0.01
Fwd EY1.49%
FCF(TTM)-0.29
FCFYN/A
OCF(TTM)-0.13
OCFYN/A
SpS2.4
BVpS1.5
TBVpS1.17
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -52.41% | ||
| ROE | -96.67% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 8.1% | ||
| FCFM | N/A |
ROA(3y)-54.86%
ROA(5y)-35.31%
ROE(3y)-196.24%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-17.56%
GM growth 5Y4.63%
F-Score5
Asset Turnover0.87
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.25 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 363.84% | ||
| Cap/Sales | 6.97% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.44 | ||
| Quick Ratio | 1.24 | ||
| Altman-Z | -1.91 |
F-Score5
WACC6.89%
ROIC/WACCN/A
Cap/Depr(3y)618.49%
Cap/Depr(5y)438.25%
Cap/Sales(3y)5.46%
Cap/Sales(5y)3.66%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)71.84%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-70.16%
EPS Next Y-21.87%
EPS Next 2Y41.97%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)13.03%
Revenue growth 3Y-1.24%
Revenue growth 5Y7.56%
Sales Q2Q%-3.22%
Revenue Next Year6.66%
Revenue Next 2Y15.46%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-28.29%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year67.01%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-5.16%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y51.94%
OCF growth 3YN/A
OCF growth 5YN/A